Role of histone modifications in neurogenesis and neurodegenerative disease development
- PMID: 38762100
- DOI: 10.1016/j.arr.2024.102324
Role of histone modifications in neurogenesis and neurodegenerative disease development
Abstract
Progressive neuronal dysfunction and death are key features of neurodegenerative diseases; therefore, promoting neurogenesis in neurodegenerative diseases is crucial. With advancements in proteomics and high-throughput sequencing technology, it has been demonstrated that histone post-transcriptional modifications (PTMs) are often altered during neurogenesis when the brain is affected by disease or external stimuli and that the degree of histone modification is closely associated with the development of neurodegenerative diseases. This review aimed to show the regulatory role of histone modifications in neurogenesis and neurodegenerative diseases by discussing the changing patterns and functional significance of histone modifications, including histone methylation, acetylation, ubiquitination, phosphorylation, and lactylation. Finally, we explored the control of neurogenesis and the development of neurodegenerative diseases by artificially modulating histone modifications.
Keywords: Histone modifications; Neural Stem Cells; Neurodegenerative disease; Neurogenesis; Neuron.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare no competing interests
Similar articles
-
Evaluation of post-translational modifications in histone proteins: A review on histone modification defects in developmental and neurological disorders.J Biosci. 2020;45:135. J Biosci. 2020. PMID: 33184251 Review.
-
The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications.Front Immunol. 2024 Nov 15;15:1495221. doi: 10.3389/fimmu.2024.1495221. eCollection 2024. Front Immunol. 2024. PMID: 39620228 Free PMC article. Review.
-
Histone Methylation Regulation in Neurodegenerative Disorders.Int J Mol Sci. 2021 Apr 28;22(9):4654. doi: 10.3390/ijms22094654. Int J Mol Sci. 2021. PMID: 33925016 Free PMC article. Review.
-
Histone post-translational modifications to target memory-related diseases.Curr Pharm Des. 2013;19(28):5065-75. doi: 10.2174/1381612811319280005. Curr Pharm Des. 2013. PMID: 23448462 Review.
-
Histone H1 Post-Translational Modifications: Update and Future Perspectives.Int J Mol Sci. 2020 Aug 18;21(16):5941. doi: 10.3390/ijms21165941. Int J Mol Sci. 2020. PMID: 32824860 Free PMC article. Review.
Cited by
-
GSK-3β and mTOR Phosphorylation Mediate the Reversible Regulation of Hypomagnetic Field on Adult Neural Stem Cell Proliferation.Eur J Neurosci. 2025 Jul;62(2):e70202. doi: 10.1111/ejn.70202. Eur J Neurosci. 2025. PMID: 40676806 Free PMC article.
-
Histone modifications in cervical cancer: Epigenetic mechanisms, functions and clinical implications (Review).Oncol Rep. 2025 Oct;54(4):131. doi: 10.3892/or.2025.8964. Epub 2025 Aug 8. Oncol Rep. 2025. PMID: 40776754 Free PMC article. Review.
-
Autoimmune disease: a view of epigenetics and therapeutic targeting.Front Immunol. 2024 Nov 13;15:1482728. doi: 10.3389/fimmu.2024.1482728. eCollection 2024. Front Immunol. 2024. PMID: 39606248 Free PMC article. Review.
-
Metabolic reprogramming of astrocytes: Emerging roles of lactate.Neural Regen Res. 2026 Feb 1;21(2):421-432. doi: 10.4103/NRR.NRR-D-24-00776. Epub 2024 Dec 16. Neural Regen Res. 2026. PMID: 39688570 Free PMC article.
-
Potential therapeutic targets for ischemic stroke in pre-clinical studies: Epigenetic-modifying enzymes DNMT/TET and HAT/HDAC.Front Pharmacol. 2025 Apr 28;16:1571276. doi: 10.3389/fphar.2025.1571276. eCollection 2025. Front Pharmacol. 2025. PMID: 40356977 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous